Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck

Smokers with squamous cell carcinoma of the head and neck (SCCHN) have a particularly poor prognosis when compared with human papillomavirus-positive SCCHN. Here, we present case reports of two smokers with SCCHN treated with cetuximab-based therapy, highlighting the potential benefit of cetuximab b...

Descripción completa

Detalles Bibliográficos
Autores principales: Knutzen, Greg, Subbiah, Shanmuga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: November, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677711/
https://www.ncbi.nlm.nih.gov/pubmed/26668572
http://dx.doi.org/10.1159/000441019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677711/
https://www.ncbi.nlm.nih.gov/pubmed/26668572
http://dx.doi.org/10.1159/000441019

Ejemplares similares